45 studies found for:    " May 26, 2010":" June 25, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Not yet recruiting Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
22 Completed A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Simvastatin;   Drug: Atorvastatin;   Drug: Rosuvastatin
23 Completed The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
Conditions: HIV Infections;   Varicella-Zoster Virus
Intervention: Biological: VZV vaccination
24 Completed Male Involvement in Antenatal Care and the Prevention Programme of Mother-to-child Transmission of HIV in Uganda
Condition: HIV Infection
Interventions: Behavioral: Invitation letter for male spouse;   Behavioral: Information letter
25 Completed Treatment Options for Protease Inhibitor-exposed Children
Conditions: HIV/AIDS;   HIV Infections
Interventions: Drug: Efavirenz;   Drug: Lopinavir/ritonavir (LPV/r);   Drug: D4T;   Drug: Abacavir (ABC)
26 Active, not recruiting Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)
Condition: HIV Infections
Intervention: Drug: ATV/r
27 Completed Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children
Condition: HIV-1 Infections
Intervention: Other: lopinavir/ritonavir
28 Completed Lopinavir (LPV) Dose Reduction
Condition: HIV-1 Infections
Interventions: Drug: Generic LPV/r and Aluvia (pharmacokinetics);   Drug: Aluvia and Generic LPV/r (pharmacokinetics)
29 Terminated MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)
Condition: HIV-1 Infection
Interventions: Drug: MK6186;   Drug: Comparator: Placebo
30 Completed Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults
Condition: HIV-1 Infection in Adults (Asymptomatic)
Intervention: Drug: Antibody UB-421
31 Completed Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia
Condition: HIV
Intervention:
32 Completed Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi
Condition: HIV
Interventions: Drug: Copper IUD;   Drug: Depo Medroxyprogesterone acetate
33 Recruiting Selective Exposure in HIV Prevention
Condition: HIV Infections
Interventions: Other: Instrumental meta intervention;   Other: Empowering meta-intervention;   Other: Control
34 Completed A Safety Study to Assess the Delivery of Dapivirine From a Matrix Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
35 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
36 Completed Tenofovir Gel in Pregnancy and Lactation
Condition: HIV Infections
Interventions: Drug: Tenofovir 1% gel;   Other: Placebo gel
37 Completed
Has Results
Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data
Condition: HIV Infections
Intervention:
38 Completed Dermal HIV-1 Immunization During Anti-retroviral Therapy Followed by Repeated Treatment Interruptions
Condition: HIV-1
Intervention: Biological: HIV DNA Vaccine
39 Terminated
Has Results
Pregabalin Trial In HIV Neuropathic Pain
Conditions: HIV-1 Infection;   Neuropathic Pain
Intervention: Drug: pregabalin (Lyrica)
40 Completed Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults
Condition: HIV-1 Infections
Interventions: Biological: ChAdV63.HIVconsv low dose.;   Biological: ChAdV63.HIVconsv high dose.;   Biological: pSG2.HIVconsv;   Biological: MVA.HIVconsv;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years